1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Lifenet Insurance Company
  6. News
  7. Summary
    7157   JP3966660007

LIFENET INSURANCE COMPANY

(7157)
  Report
Delayed Japan Exchange  -  12:30 2022-08-15 am EDT
865.00 JPY   +1.17%
08/10Lifenet Insurance Company Reports Earnings Results for the First Quarter Ended June 30, 2022
CI
08/09LIFENET INSURANCE : Eisai and Lifenet Enter Into Capital and Business Alliance Agreement Aimed at Building Ecosystem to Reduce Burden of Medical and Nursing Care
PU
08/05JULY 2022 : Monthly disclosure
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Agnelli's Exor expands in healthcare with 10% stake in Institut Merieux

07/01/2022 | 12:04pm EDT

MILAN, July 1 (Reuters) - Italy's Agnelli family, whose investments include carmaker Stellantis and soccer club Juventus, is set to buy a slice of French healthcare group Institut Merieux for 833 million euros ($867 million) through its Exor holding company.

The deal, announced on Friday by the two companies, will see privately-held Institut Merieux selling a 10% stake to Exor through a reserved capital increase.

It marks the first major international move into the healthcare business by Exor, which will soon have 9 billion euros to invest after it completes the sale of Bermuda-based reinsurer Partner Re.

CEO John Elkann, the scion of the Agnelli family, has said Exor's new investments would focus on the healthcare, technology and luxury sectors. In luxury, Exor already owns 24% in high-end shoemaker Louboutin and is the largest shareholder in Chinese group Shang Xia.

"For us, this is a unique opportunity to enter the healthcare sector with a strong partner with whom we share the same values and long-term horizon," Elkann said in the statement.

Lazard advised Lyon-based Institut Merieux on the deal alongside French lawyers Juris Vendome and Gide Loyrette Nouel, while Exor was represented by Paris-based law firm De Pardieu Brocas Maffei.

Founded 125 years ago, Institut Merieux employs over 21,000 people globally, with a turnover of 4 billion euros. It controls five companies in different healthcare segments, including Paris-listed bioMerieux, whose market capitalisation tops 11 billion euros.

The deal, which values Institut Merieux at over 8 billion euros, is expected to be completed during the summer. Exor will pay one third of the agreed amount at the closing of the deal and the remainder within the following 12 months.

Elkann and Exor partner Benoit Ribadeau Dumas will join Institut Merieux's board.

Exor - which is the single largest shareholder in Stellantis and has controlling stakes in companies including sports car maker Ferrari and Serie A soccer team Juventus - earlier this year bought a 45% stake in Italy's Lifenet Healthcare for 67 million euros.

($1 = 0.9611 euros) (Reporting by Giulio Piovaccari Additional reporting by Pamela Barbaglia Editing by Giulia Segreti and Mark Potter)


© Reuters 2022
Stocks mentioned in the article
ChangeLast1st jan.
BIOMÉRIEUX -3.50% 102.15 Real-time Quote.-18.21%
EXOR N.V. -0.36% 65.88 Delayed Quote.-16.57%
FERRARI N.V. 0.25% 215.81 Delayed Quote.-16.62%
JUVENTUS FOOTBALL CLUB S.P.A. 0.26% 0.3814 Delayed Quote.10.55%
LIFENET INSURANCE COMPANY 1.29% 865 Delayed Quote.-6.66%
STELLANTIS N.V. 0.99% 14.832 Delayed Quote.-11.11%
STELLANTIS N.V. 1.10% 14.842 Real-time Quote.-11.01%
All news about LIFENET INSURANCE COMPANY
08/10Lifenet Insurance Company Reports Earnings Results for the First Quarter Ended June 30,..
CI
08/09LIFENET INSURANCE : Eisai and Lifenet Enter Into Capital and Business Alliance Agreement A..
PU
08/05JULY 2022 : Monthly disclosure
PU
08/02Lifenet Insurance Grants Restricted Stock Compensation
MT
08/02LIFENET INSURANCE : Notice of Completion of Payment Related to New Share Issue for Restric..
PU
07/25LIFENET INSURANCE : Presentation Material for Business Plan and Growth Potential
PU
07/14Lifenet Insurance Schedules Restricted Stock Compensation
MT
07/13LIFENET INSURANCE : Notice of New Share Issue for Restricted Stock Compensation
PU
07/01Agnelli's Exor expands in healthcare with 10% stake in Institut Merieux
RE
06/21Certain Common Stock of SUSMED,Inc. are subject to a Lock-Up Agreement Ending on 21-JUN..
CI
More news
Financials
Sales 2023 29 700 M 222 M 222 M
Net income 2023 -2 676 M -20,0 M -20,0 M
Net Debt 2023 - - -
P/E ratio 2023 -22,2x
Yield 2023 -
Capitalization 59 625 M 446 M 446 M
Capi. / Sales 2023 2,01x
Capi. / Sales 2024 1,86x
Nbr of Employees 174
Free-Float 76,1%
Chart LIFENET INSURANCE COMPANY
Duration : Period :
Lifenet Insurance Company Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends LIFENET INSURANCE COMPANY
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Mean consensus -
Number of Analysts 0
Last Close Price 855,00
Average target price
Spread / Average Target -
EPS Revisions
Managers and Directors
Ryosuke Mori Director, Executive Officer & GM-Sales
Hitoshi Hatta Managing Director & Chief Compliance Officer
Masanobu Takatani Independent Outside Director
Keiko Hayashi Independent Outside Director
Masayuki Nishida Director, Chief Human Resources Officer & EVP
Sector and Competitors
1st jan.Capi. (M$)
LIFENET INSURANCE COMPANY-6.66%446
AXA-6.76%59 025
METLIFE, INC.8.51%54 086
AFLAC INCORPORATED9.66%40 462
PRUDENTIAL FINANCIAL, INC.-2.54%39 242
MANULIFE FINANCIAL CORPORATION1.24%36 373